Brefeldin A redistributes resident and itinerant Golgi proteins to the endoplasmic reticulum by unknown
Brefeldin A Redistributes Resident and Itinerant Golgi Proteins 
to the Endoplasmic Reticulum 
Robert W. Doms, Gustav Russ, and Jonathan W. Yewdell 
Laboratory of Viral Diseases, National Institutes of Health, Bethesda, Maryland 20892 
Abstract.  Brefeldin A  (BFA) has been reported to 
block protein transport  from the ER and cause disas- 
sembly of the Golgi complex. We have examined the 
effects of BFA on the transport and processing of the 
vesicular stomatitis virus G protein,  a  model integral 
membrane protein.  Delivery of G protein to the cell 
surface was reversibly blocked by 6 #g/ml  BFA. 
Pulse-label experiments  revealed that in the presence 
of BFA, G  protein became completely resistant to en- 
doglycosidase H  digestion.  Addition of sialic acid, a 
trans-Golgi event, was not observed. Despite process- 
ing by cis- and medial Golgi enzymes, G  protein was 
localized by indirect immunofluorescence to a reticular 
distribution characteristic of the ER.  By preventing 
transport of G  protein from the ER with the metabolic 
inhibitor carbonyl cyanide m-chlorophenylhydrazone or 
by use of the temperature-sensitive  mutant ts045, 
which is restricted to the ER at 40°C,  we showed that 
processing of G protein occurred in the ER and was 
not due to retention of newly synthesized Golgi en- 
zymes. Rather,  redistribution of preexisting cis and 
medial Golgi enzymes to the ER occurred as soon as 
2.5 min after addition of BFA, and was complete by 
10-15  min.  Delivery of Golgi enzymes to the ER was 
energy dependent and occurred only at temperatures 
>~20°C. BFA also induced retrograde transport of G 
protein from the medial Golgi to the ER.  Golgi en- 
zymes were completely recovered from the ER  10 min 
after removal of BFA. These findings demonstrate that 
BFA induces retrograde transport of both resident and 
itinerant  Golgi proteins to the ER in a  fully reversible 
manner. 
p 
ROTEINS exported to the cell surface are translocated 
into the ER and then sequentially  transported through 
the cis-, medial, and trans-compartments  of the Golgi 
complex, ultimately reaching the plasma membrane (Palade, 
1975; Pfeffer and Rothman,  1987). Each compartment of the 
exocytic pathway has a unique complement of resident pro- 
teins, some of which catalyze specific posttranslational  mod- 
ifications. A central problem in cell biology is how the vari- 
ous subcompartments  of the exocytic  pathway are able to 
distinguish  and  sort  resident  from  itinerant  proteins  and 
thereby maintain  their  characteristic  composition. 
There has been some progress in understanding  the sorting 
of proteins  in the ER.  For at least  some proteins,  correct 
folding and assembly into oligomers is required for transport 
to the Golgi complex (for review see Rose and Doms, 1988). 
Improperly folded molecules retained  in the ER are eventu- 
ally degraded (Lippincott-Schwartz  et al.,  1988). A second 
regulatory mechanism must account for the retention of cor- 
rectly folded,  resident ER molecules. A number of soluble 
ER proteins possess the carboxy-terminal  sequence KDEL, 
which  is  involved  in  their  retention  (Munro and  Pelham, 
1987).  Pelham  has  proposed that  a  KDEL receptor in an 
early Golgi compartment  recognizes  the KDEL sequence 
and recycles the protein to the ER (Pelham,  1988; Pelham 
et al.,  1988). The possibility of recycling Golgi contents  to 
the ER is supported by the finding that fully 50% of the phos- 
pholipid  in the ER is transported  to the Golgi every 10 min 
(Wieland et al.,  1987). Since this tremendous efflux of lipid 
is only partially compensated for by de novo synthesis, lipids 
must be returned  to the ER from more distal compartments 
in the exocytic pathway, most likely  the Golgi or an inter- 
mediate  compartment between the Golgi and ER. If lipids 
are recycled in vesicular form, the potential for protein recy- 
cling  is clear. 
To further characterize  membrane transport between the 
ER and Golgi complex, we have examined the effects of bre- 
feldin A (BFA)  ~  on the intracellular  transport of the vesicu- 
lar stomatitis virus (VSV) G protein.  BFA is a fungal metabo- 
lite that has been shown to reversibly inhibit the secretion of 
albumin and thyroid  stimulating  hormone and the delivery 
of the VSV G protein to the plasma membrane (Takatsuki and 
Tamura,  1985; Misumi et al.,  1986;  Magner and Papagi- 
annes,  1988; Fujiwara et al.,  1988). Morphological studies 
have shown that BFA causes disassembly of the Golgi  ap- 
paratus and,  after prolonged treatment,  dilation  of the ER 
(Fujiwara  et al.,  1988).  Retained  proteins remain  in high- 
mannose forms, consistent with a block in transport between 
the ER and Golgi (Takatsuki and Tamura,  1985; Misumi et 
al.,  1986). 
1. Abbreviations usedin thispaper: BFA, brefeldin A; CCCP, carbonyl cya- 
nide m-chlorophenylhydrazone; endo D, endoglycosidase D; endo H, en- 
doglycosidase H; TXI00, Triton X-100, 
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Golgi proteins are returned to the ER when cells are treated 
with BFA. We show that G protein synthesized in the pres- 
ence of BFA is fully processed by cis- and medial Golgi car- 
bohydrate-processing enzymes. Processing occurs in the ER 
and is due to a rapid redistribution of preexisting Golgi en- 
zymes to the ER.  Redistribution is temperature and energy 
dependent, and recovery from the effects of BFA are equally 
as rapid. Our results suggest that BFA may prove to be an 
important compound for studying membrane traffic between 
the ER and Golgi complex,  and may reveal an underlying 
Golgi to ER recycling pathway. 
Materials and Methods 
Materials 
The natural BFA we used in this study was kindly provided by Drs. A. Takat- 
suki (University of Tokyo, Tokyo, Japan) and C. R. Hutchinson (University 
of  Wisconsin, Madison, WI), while synthetic BFA was provided by Dr. E. J. 
Corey (Harvard University, Cambridge, MA). BFA was kept as a 10 mg/ml 
stock at -20°C in MeOH. Virus stocks as well as Chinese hamster ovary 
(CHO) wild-type and 15B cells were provided by A. DeSilva (Yale University, 
New Haven, CT). Polyclonal antibody to VSV was a gift from J. K. Rose 
and M. A. Whitt (Yale University), and the monoclonal antibodies I1 and 
I14 were provided by D. Lyles (Bowman Gray School of Medicine, Wake 
Forest, IL). Endoglycosidase H (endo H) and endoglycosidase D (endo D) 
were both from Boehringer-Mannheim Diagnostics, Inc.  (Houston, TX) 
and  [35S]methionine  was purchased from ICN Biomedicals Inc.  (Irvine, 
CA). 
Labeling of Cells 
Cells  were  infected  with  the  Indiana  serotype  of  VSV  or  with  the 
temperature-sensitive mutant tsO45 as previously described at 37 or 32°C, 
respectively (Balch et al.,  1986).  Labeling was preformed either with the 
cells adherent to the dish or while in suspension. Cells were washed once 
with PBS and placed in methionine-free medium lacking bicarbonate and 
with 20 mM Hepes pH 7.4  15 min before the addition of 135S]methionine. 
Labeling was terminated by the addition of 1 mM cold methionine diluted 
from a 1,000 x  stock. Carbonyl cyanide m-chlorophenylhydrazone (CCCP) 
was added to a final concentration of 300 p.M in glucose-free medium. The 
appropriate temperature was maintained by circulating water baths. Cells 
in suspension were lysed by addition of Triton X-100 (TX100) to a final con- 
centration of 1%  while adherent cells were lysed with PBS/1.0%  TX100. 
When needed, anisomycin was added to a final concentration of 26/~g/ml. 
Trimerization Assay 
VSV G protein forms noncovalently associated trimers shortly after biosyn- 
thesis that can be detected by sucrose density gradient centrifugation at pH 
5.8 (Doms et al., 1987). The acid pH serves to stabilize preexisting trimers, 
rather than to catalyze their formation. When trimer formation was to be 
monitored cells were lysed at pH  5.8  with MNT  buffer (20  mM 2-(N- 
morpholino) ethane sulfonic acid,  100 mM NaCI, 30 mM Tris) containing 
1.0% TX100.  A 200-#1 aliquot was loaded onto a 5-20% (wt/vol) continu- 
ous sucrose gradient in MNT buffer, pH 5.8, with 0.1% (wt/vol) TX100. The 
samples were centrifuged for 16 h at 4%000 rpm in a SW55 rotor (Beckman 
Instruments, Inc., Palo Alto, CA) at 4°C. A total of 16 fractions were col- 
lected from the bottom of the tube with a Beckman fraction recovery system, 
and the bottom 12 fractions were immunoprecipitated with antibodies to G 
protein and analyzed by SDS-PAGE as described below. 
lmmunoprecipitations and Endoglycosidase Digestions 
Monoclonal or polyclonal antibodies were added to samples in sufficient 
quantity to insure immunoprecipitation of >-90 % of the G protein. Antibod- 
ies were incubated with samples for either 60 min at 4°C or 30 min at 37°C. 
75 #1 of protein A-Sepharose (Pharmacia Inc., Piscataway, NJ) was added, 
and the sample gently mixed for 15-30 rain. The samples were washed once 
by addition of 1 ml 0.1 M Tris pH 8.0, 0.5 M NaCI pH 8.0 and once by addi- 
tion of 1 ml dH20.  Samples were resuspended in Laemmli sample buffer 
with/3-mercaptoethanol for SDS-PAGE. For endo H digestions, samples 
were resuspended in 50 #1 of 0.1 M Na acetate pH 5.5 with 0.5% SDS and 
boiled for 5 rain. The samples were then divided into two equal sized ali- 
quots and an equivalent volume of 0.1  M Na acetate pH 5.5 without SDS 
and containing 0.5 mU endo H was added to one of the aliquots. Digestion 
was for 16 h at 37°C, after which an equal volume of 2x sample buffer con- 
raining 2% SDS was added. Endo D digestions were carried out essentially 
as described by Beckers et al. (1987).  Cells were lysed in 10 mM Tris (pH 
7.4),  200 mM NaC1, and 1% TXI00. An aliquot of the lysate was digested 
with 2 mU endo D for 16 h at 37°C. The samples were then immunoprecipi- 
tated and prepared for SDS-PAGE as usual. 
Immunofluorescence 
Immunofluorescence was performed essentially as described Timm et al. 
(1983).  Cells were fixed with 3% paraformaldehyde and permeabilized with 
Triton X-100 as required. A mixture of  two monoctonal antibodies to G pro- 
tein (I14 and 117) were used. I17 efficiently recognizes misfolded forms of 
G protein while I14 reacts well with properly folded molecules (Doms et 
al., 1988).  FITC-conjugated goat anti-mouse from Tago Inc. (Burlingame, 
CA) was used as the second antibody. Identical exposures were taken of all 
samples using a Zeiss Axiophot Photomicroscope. 
Results 
BFA Inhibits Transport of G Protein 
to the Cell Surface 
BFA has been reported to inhibit protein transport from the 
ER and cause disassembly of the Golgi complex (Misumi et 
al., 1986; Fujiwara et al., 1988). To more fully characterize 
the subcellular location(s) at which BFA exerts its effects, we 
examined the intracellular transport of the VSV G  protein 
by  indirect  immunofluorescence.  G  protein  is  an  integral 
membrane protein that is exceptionally well characterized. 
It  contains  two  N-linked  oligosaccharides  (Rothman  and 
Lodish,  1977;  Rose  and  Gallione,  1981;  Machamer  and 
Rose,  1988a, b) and forms noncovalently associated trimers 
before exit from the ER (Kreis and Lodish,  1986; Doms et 
al.,  1987). G protein is then transported through the Golgi 
apparatus  where its sugers are  modified to complex forms 
before delivery to the plasma membrane (Kornfeld and Korn- 
feld,  1985;  Farquhar,  1985). 
BFA was added at 6/~g/ml to the culture medium of CHO 
cells  1 h after  infection with the Indiana serotype of VSV. 
4 h after infection, cells were fixed and prepared for indirect 
immunofluorescence. Little or no G protein was found on the 
surface of BFA-treated  cells, in marked contrast to untreated 
controls.  Surface  expression  was  not observed  even when 
cells were examined 7 h after infection, suggesting that the 
transport block was. absolute rather  than kinetic in nature. 
When  BFA-treated  cells  were  permeabilized  with  Triton 
X-100, the nuclear membrane and a reticular network char- 
acteristic  of the ER  were  stained  (Fig.  1 A).  Indeed,  the 
distribution of G  protein within BFA-treated  cells  was  in- 
distinguishable from cells  expressing  the G  protein of the 
temperature-sensitive mutant tsO45, which is restricted ex- 
clusively to the ER at nonpermissive temperature (for exam- 
ple, Fig.  10 C, Bergmann et al., 1981; Bergmann and Singer, 
1983).  Additionally, a number of small vesicles containing 
G protein were easily discerned. 
To determine if the effects of BFA were reversible,  BFA- 
treated  cells  were  washed  and  placed  in  normal  growth 
medium without BFA. Anisomycin was added 30 min before 
the removal of BFA to prevent additional protein synthesis, 
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infection, BFA was added to a final concentration of 6 ttg/ml. Anisomycin was added for 30 min and the BFA then removed for 0  (A), 
5  (B),  10 (C), or 15 rain (D). BFA was added again to cells for either 5  (E) or 10 (F) min after a  15-min  washout period. The cells 
were fixed, permeabilized, and prepared for indirect immunofluorescence as described in Materials and Methods. Bar,  15 #m. 
enabling us to monitor the distribution of G  protein mole- 
cules that had accumulated at the BFA block. As shown in 
Fig. 1 B, the distribution of G protein changed from a reticu- 
lar to a  punctate pattern 5  rain after removal of BFA, with 
vacuolar staining evident throughout the cytoplasm. By  10 
rain the vacuoles had begun to concentrate around the nu- 
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sembly of G protein. (A) CHO cells infected 
with wild-type or ts045 VSV were labeled 
with [35S]methionine for 30 min at 37°(for 
wild type) or at either 32 or 40°C for ts045. 
The cells were then chased in the presence 
of excess cold methionine  at the indicated 
temperature  for 30 min,  iysed in TX100, 
and  aliquots  immunoprecipitated  with  a 
polyclonal  antibody  to  VSV  (P)  or  with 
monoclonal antibodies  I1  (A) or I14 (B). 
The  immunoprecipitations  were  quantita- 
tive judging by the failure to precipitate  ad- 
ditional  G  protein  after  the  initial  round. 
The samples were analyzed by SDS-PAGE. 
BFA was present for 30 min before the pulse- 
label  as well  as during the pulse  and the 
chase periods  where  indicated.  (B)  Cells 
infected  with  wild-type VSV were labeled 
for  10 min,  chased for  10 min,  and then 
lysed with 1% TX100 in MNT buffer at pH 
5.8. BFA was added to cells 30 min before 
labeling  where  indicated.  Aliquots  were 
centrifuged on continuous sucrose gradients 
to separate 8 S trimers from 4 S monomers. 
The gradients  were fractionated  and each 
fraction immunoprecipitated  and analyzed 
by SDS-PAGE. The band migrating immed- 
iately  beneath  G  protein  is  Gs,  a  water- 
soluble,  truncated  form of G  protein  se- 
creted during the course of infection  (Little 
and Huang,  1978). 
cleus (Fig.  1 C) and 15 min after BFA removal the vacuoles 
had coalesced to a juxtanuclear location typical of the Golgi 
complex (Fig.  1 D).  After an additional  15 min,  G  protein 
could be detected on the cell surface.  Thus, the BFA block 
was rapidly overcome upon removal of the drug,  in agree- 
ment with previous results (Misumi et al.,  1986; Takatsuki 
and Tamura,  1985). 
BFA Does Not Affect Folding or Assembly of G Protein 
We first determined if the effects of BFA on transport were 
due to alterations  in the folding or assembly of G  protein. 
Newly  synthesized  G  protein  monomers  fold and  acquire 
disulfide  bonds  before  the  formation  of noncovalently as- 
sociated trimers in the ER (Kreis and Lodish,  1986; Doms 
et al.,  1987,  1988). Only properly folded trimers are trans- 
ported  to  the  cell  surface.  To monitor folding,  we used  a 
pulse-chase radiolabeling protocol followed by detergent ex- 
traction  and  immunoprecipitation  with  the  conformation 
specific  monoclonal  antibodies  I1  and  I14.  The  epitopes 
defined by these antibodies are acquired  1-2 min after syn- 
thesis (LeFrancois and Lyles,  1982; Doms et al.,  1988).  G 
protein synthesized in the presence of BFA was immunologi- 
cally  indistinguishable  from protein  synthesized  in  its  ab- 
sence (Fig.  2  A).  By contrast,  G  protein  from the temper- 
ature-sensitive  mutant,  ts045,  which  folds  abnormally  at 
elevated temperatures (Kreis and Lodish, 1986; Doms et al., 
1987,  1988), reacted poorly with the antibodies (Fig.  2 A). 
To monitor trimerization of G  protein, detergent extracts of 
pulse-labeled cells were centrifuged on continuous sucrose 
gradients  designed  to differentiate 4  S  monomers and  8  S 
trimers (Doms et al.,  1987). BFA did not affect the efficiency 
or rate of trimer formation (Fig.  2  B,  for example).  These 
findings indicate that the effects of BFA on the transport of 
G  protein cannot be ascribed to alterations  in its folding or 
assembly. 
Figure 3.  Trimming of G protein by cis-Golgi man- 
nosidase.  CHO15B  cells  incubated  with or without 
BFA were pulse-labeled  for 5 min and then chased for 
various  times.  Cells  were lysed  and  the  lysates  in- 
cubated with 2.5 mU endo D for 16 h at 37°C. The 
samples  were then immunoprecipitated  with a poly- 
clonal antibody to G protein,  and the samples  ana- 
lyzed by SDS-PAGE. In the first lane,  all of the G protein is resistant  to digestion  with endo D, indicating  it has not yet been trimmed 
to the MansGlcNAc2 form. In contrast, three bands are seen in the seventh lane,  representing  G protein molecules with 0, 1, or 2 trimmed 
chains. 
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H  resistant  in  the  presence  of 
BFA.  Cells  were  labeled  with 
[35S]methionine  for  10 min  and 
then chased for the indicated  pe- 
riods  of time  before  lysis  with 
TX100.  G  protein  was  immuno- 
precipitated  and  incubated  with 
(+)  or  without  (-)  endo  H  at 
37°C overnight.  (A) Cells without 
BFA and CCCP.  An increase  in 
molecular weight due to addition 
of sialic  acid is seen  by 15 rain, 
and  was  complete  by  30  min. 
Neuraminidase  digestion  con- 
firmed that the decrease in mobil- 
ity was due to sialic acid addition 
(far right). (B ) Cells were treated 
with BFA 30 min before labeling, 
as  well  as during  the  label  and 
chase periods. Neuraminidase di- 
gestion confirmed that sialic acid 
was  not added to the G protein. 
(C) CCCP was added to a final concentration of 10/~g/ml immediately  after the 10-min labeling period. (D) Cells were treated  with BFA 
(5 #g/ml) for 30 min before the 10-rain label.  CCCP was added immediately  after the labeling  period, and the BFA was removed 5 min 
later.  The cells  were then incubated  with  CCCP alone for the remainder of the chase period. 
Carbohydrate Processing by cis-Golgi Enzymes Occurs 
in the Presence of BFA 
To more precisely determine  the site at which transport of 
G protein to the cell surface was blocked, we monitored pro- 
cessing  of G  protein's  two  N-linked  oligosaccharides.  By 
using SDS-PAGE and several endoglycosidases, it is possible 
to determine if N-linked carbohydrate side chains have been 
modified by enzymes associated with either the cis-, medial, 
or  trans-Golgi  (Kornfeld  and  Kornfeld,. 1985;  Farquhar, 
1985;  Dunphy  and  Rothman,  1985).  Initially,  N-linked 
oligosaccharides are trimmed from the high-mannose forms 
found  in  the  ER  to  MansGlcNAc2  by alpha-l,  2-mannosi- 
dase I in the cis-Golgi.  Normally, GlcNAc residues are rap- 
idly added to MansGlcNAc2 oligosaccharides (Kornfeld and 
Kornfeld,  1985;  Farquhar,  1985).  In CHO  15B cells,  how- 
ever, the medial Golgi processing enzyme, N-acetylglucos- 
amine  transferase,  is  absent.  Consequently,  G  protein  ac- 
cumulates  in the electrophoretically distinct  MansGlcNAcz 
form (Schlesinger et al., 1976). This down-shift in molecular 
weight can be  enhanced by digestion  with endo D,  which 
removes  only  MansGlcNAc2  oligosaccharides  (Tai  et  al., 
1975; Mizuochi et al., 1984; Beckers et al.,  1987). The com- 
bination of CHO 15B cells and endo D  digestion thus pro- 
vides a sensitive and specific assay for exposure of G protein 
to a  cis-Golgi  enzyme (Beckers  et al.,  1987). 
BFA was added to infected CHO 15B cells 30 min before 
a  5-min pulse-label  with  [35S]methionine,  after which cells 
were chased in the presence of excess unlabeled methionine 
for various periods of  time. Cell extracts were incubated with 
endo D, and the G protein immunoprecipitated and analyzed 
by SDS-PAGE. As shown in Fig. 3, approximately half of the 
Figure 5. tsO45 becomes endo H 
resistant  at  nonpermissive  tem- 
perature. Cells infected with tsO45 
were  labeled  for  10  min  at  the 
indicated  temperature  and  then 
chased for 0 or 90 min. The cells 
were lysed and the G protein  im- 
munoprecipitated  and  incubated 
overnight  with  (+)  or  without 
(-) endo H. BFA was added im- 
mediately  after  the  pulse-label 
where  indicated.  To  show  that 
processing at 40°C was not due to 
retention  of  newly  synthesized 
Golgi enzymes, anisomycin was added immediately  after the labeling period for 60 min to inhibit further protein synthesis.  BFA was then 
added for an additional  90 min, also in the presence of anisomycin,  before the cells were lysed.  Finally, CCCP was added to cells labeled 
at 40°C immediately after the labeling  period. BFA was added 5 min later and the cells  incubated  for an additional  85 min at 40°C. The 
G protein remained  endo H  sensitive,  demonstrating that  redistribution  was energy dependent. 
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the absence of BFA.  Three distinct bands were observed 
(e.g., Fig. 3, seventh lane) representing molecules with 0, 1, 
or 2 trimmed N-linked oligosaccharides. In contrast, G pro- 
tein was trimmed much more slowly in the presence of BFA, 
with 50% trimming not observed until after 25 min. By 60 
min, trimming of both chains was >190% complete. 
Processing by Medial Golgi Enzymes Occurs in the 
Presence of BFA 
To determine if G protein was also exposed to medial Golgi 
processing  enzymes during the  BFA  transport block,  we 
monitored endo H  resistance in CHO wild-type cells.  In- 
fected wild-type CHO cells were treated continuously with 
BFA for a 30-min prelabeling period, a  10-min pulse label, 
and for various times of chase. As shown in Fig. 4 A, VSV 
G protein acquired endo H resistance in untreated cells with 
a  tt/2 of •15-20  min.  A  further  increase  in  molecular 
weight due to the addition of sialic acid (confirmed by neur- 
aminidase digestion, see Fig. 4 A) in the trans-Golgi was ob- 
served shortly after the acquisition of endo H resistance. In 
the presence of BFA, G protein became endo H resistant but, 
as with trimming, the process was slowed (Fig. 4 B). All of 
the G protein became partially resistant to endo H by 45 min 
of chase (Fig. 4 B). This intermediate sensitivity was infre- 
quently observed in the absence of BFA, and is consistent 
with the asynchrony observed in trimming to the MansGlc- 
NAc2 form (Fig. 3).  This is likely due to differential pro- 
cessing of the two N-linked chains. By 90 min of chase, G 
protein was >190% endo H resistant. However,  addition of 
sialic acid was not observed, even after 4 h of chase (Fig. 
4 B). Thus, G protein is exposed to medial but not trans- 
Golgi processing enzymes when its transport is blocked by 
BFA. 
Processing Occurs in the ER 
The acquisition of endo H resistance by a protein that by in- 
direct immunofluorescence appeared to be restricted to the 
ER was surprising. A number of possibilities could account 
for this observation. First, G protein could be transported to 
the Golgi, but in the presence of BFA the Golgi apparatus 
might vesiculate and thereby give rise to a reticular staining 
pattern. Alternatively, BFA could block the exit of G protein 
from the ER, and processing in the ER might be due to reten- 
tion of newly synthesized Golgi enzymes or by redistribution 
of preexisting enzymes from the Golgi complex to the ER. 
Finally, G protein might rapidly cycle between the ER and 
Golgi during BFA treatment. 
To determine if processing did in fact occur in the ER, we 
prevented transport of G  protein from this organelle using 
CCCE Protein transport is critically dependent upon cellu- 
lar energy levels (Jamieson and Palade, 1968; Balch et al., 
1986; Balch and Keller, 1986; Persson et al., 1988). CCCP 
rapidly lowers cellular ATP levels, and presumably prevents 
transport from the ER on this basis (Tartakoff and Vassalli, 
1977; Farquhar, 1985).  When CCCP was added to infected 
cells immediately after a  10-min pulse, G protein remained 
endo H sensitive throughout a 2-h chase (Fig. 4  C). Like- 
wise, no processing was observed if BFA was added in addi- 
tion to CCCP (Fig. 6, I lth and 12th lanes). However, if cells 
were pretreated with BFA for 30 min before pulse labeling 
and CCCP added immediately after the labeling period, G 
protein  became  completely endo  H  resistant (Fig.  4  D). 
Removal of BFA 5 min after addition of CCCP still resulted 
in the acquisition of endo H resistance. Thus, to acquire endo 
H resistance in the presence of CCCE it was necessary to 
preincubate cells with BFA. 
To further test the idea that processing occurred in the ER, 
we used the temperature-sensitive mutant tsO45. At the non- 
permissive  temperature  of 40°C,  tsO45  G  protein  is  re- 
stricted exclusively to the ER where it is retained in a mis- 
folded,  aggregated  state  (Lafay,  1974; Zilberstein  et  al., 
1980; Bergmann et al., 1981; Lodish and Kong, 1983; Balch 
et al.,  1986;  Doms et al.,  1987, 1988).  The distribution of 
tsO45 G at 40°C as detected by indirect immunofluorescence 
was  unaffected by the addition of BFA  (not  shown),  and 
the protein remained misfolded (Fig. 2 A) and aggregated. 
Nevertheless, tsO45  became endo H resistant at 40°C after 
a 90-min chase when BFA was added at the end of a 10-min 
pulse-label (Fig. 5). As noted for the wild-type protein, sialic 
acid was not added. Addition of CCCP immediately after the 
pulse-label prevented processing unless, as described above, 
cells  were  pretreated  with  BFA  before  labeling  and  the 
energy block (Fig. 5). Thus, a well-characterized ER marker 
became completely endo H resistant in the presence of BFA. 
Processing Is due to Redistribution of Golgi Enzymes 
Having shown that processing occurs in the ER in the pres- 
ence of BFA, we had to differentiate between processing by 
retention of newly synthesized Golgi enzymes in the ER 
versus redistribution of preexisting enzymes from the Golgi 
complex. We considered processing by newly synthesized 
enzymes to be unlikely given the fact that G protein remained 
completely endo H  sensitive when retained in the ER by 
CCCP treatment, presumably along with newly synthesized 
processing enzymes. Further, we expect that little if any pro- 
cessing enzymes are synthesized by these cells since VSV 
shuts off synthesis of most host cell proteins during infection 
(Week  et al.,  1979).  Nevertheless,  to test this hypothesis 
more fully, cells expressing tsO45 G protein were labeled for 
10 min at 40°C. Anisomycin was then added for 60 min to 
prevent additional protein synthesis and to allow newly syn- 
thesized Golgi enzymes to be cleared from the ER. Aniso- 
mycin reduced incorporation of ['S]methionine by 98%. 
Under these conditions, tsO45 G protein restricted to the ER 
remained endo H sensitive. However,  complete endo H re- 
sistance was acquired by 90 min if BFA was added after the 
60-min anisomycin pretreatment period (Fig.  5).  Thus, G 
protein restricted to the ER at 40°C was processed in the 
presence of BFA and in the absence of protein synthesis. We 
concluded that BFA induces redistribution of Golgi proteins 
into the ER. 
Kinetics of Enzyme Redistribution 
Having shown that BFA induces redistribution of enzymes 
from the Golgi apparatus to the ER and that this process 
could be completely inhibited by CCCE we were able to de- 
termine the rate at which redistribution occurred. Cells were 
treated with BFA for different  periods of time both before and 
during a 10-min pulse-label. CCCP was added immediately 
after the labeling period to prevent further redistribution and 
the cells incubated for an additional 90 min before extrac- 
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min of BFA treatment, ER-restricted G protein became com- 
pletely resistant to endo H after a 90-rain chase, and longer 
treatment times did not affect the rate of this process (Fig. 
6)1 Intermediate sensitivity was observed at other times of 
BFA treatment. For example, detectable amounts of partially 
endo H-sensitive G protein were first observed when BFA 
was added at the beginning of the 10-min pulse-label. Only 
60% of the G protein became resistant to endo H when BFA 
was  added  midway  (5  rain)  through  the  pulse-label,  and 
~20% became resistant if BFA was present only during the 
final 2.5 min of  the pulse-label. Thus, redistribution of Golgi 
enzymes could be detected as early as 2.5 min after BFA 
addition. 
The intermediate sensitivity of G  protein to endo H  ob- 
served after 2.5-10.0-min treatments with BFA followed by 
a 90-min chase in the presence of CCCP suggested that en- 
zyme redistribution was incomplete when BFA was present 
for x<10 min. If so, then a rate-limiting step in endo H resis- 
tance might be related to the concentration of Golgi enzymes 
redistributed to the ER. We therefore determined the kinetics 
with which G protein became resistant to endo H after differ- 
ent BFA treatment periods. As shown in Fig. 6  (lanes 1-4) 
and Fig. 4 B, G protein became >90%  resistant to endo H 
when cells were treated with BFA for >115 min. We found that 
G protein became >90%  resistant to endo H after 120 and 
180 min when cells were treated with BFA for 10 and 5 min, 
respectively.  G  protein became only partially  resistant  to 
endo H when cells were treated with BFA for 2.5 min regard- 
less of chase time. Complete processing to the endo H-resis- 
tant form might have been prevented due to the cytopathic 
effects associated  with  long  term  incubation  with  CCCP. 
From these results we concluded that redistribution to the ER 
begins as early as 2.5 min after addition of BFA, and was 
completed between  10 and  15 min. 
Temperature Dependence of Redistribution 
Transport between the  ER and  Golgi  is  blocked at  15°C 
(Saraste and Kuismanen, 1984; Balch et al., 1986; Balch and 
Keller, 1986; Tartakoff, 1986) while transport from the trans- 
Golgi to the plasma membrane can be blocked at 20°C (Mat- 
lin and Simons, 1983; Saraste and Kuismanen, 1984; Fuller 
et al.,  1985; Griffiths et al.,  1985).  It was therefore of in- 
terest  to  examine  the  temperature  dependence  of  BFA- 
induced redistribution of Golgi enzymes to the ER.  Cells 
were labeled with [3sS]methionine for 10 min, after which 
they were chased at 37, 20, 15, or 0°C in the presence of BFA 
for 90 or  180 rain. As shown in Fig. 7, G protein became 
endo H resistant at 37 and 20°C, but not at 15 or 0°C, sug- 
gesting that redistribution occurred only at the higher tem- 
peratures.  Alternatively, redistribution at  15°C might have 
remained  undetected if processing  itself was  directly  in- 
hibited. To rule at this possibility, cells were pretreated with 
BFA for 30 rain at 37°C, labeled for 10 min at 37°C, and then 
chased at 15°C. Under these conditions, when redistribution 
was allowed to occur 37°C but processing had to occur at 
15°C, the G protein became endo H resistant after a 180-min 
chase. Thus, had redistribution occurred at 15°C, G protein 
would have been processed.  Taken together, these experi- 
ments show that redistribution of Golgi enzymes only oc- 
curred at temperatures >15°C. 
Kinetics of Enzyme Recovery After Removal of BFA 
As shown in Fig.  1, the BFA-induced transport block of G 
protein was rapidly overcome upon removal of BFA. We next 
determined the kinetics with which Golgi enzymes were re- 
covered from the ER and returned to the Golgi apparatus 
once BFA was removed. To monitor enzyme recovery, cells 
were treated with BFA for 30 rain to induce complete redis- 
tribution of enzymes to the ER. BFA was then removed for 
various periods of time before a 5-min label. Further mem- 
brane  transport  was  then  inhibited by addition  of CCCP. 
Thus, by determining the period of time cells had to remain 
in BFA-free medium before G protein restricted to the ER by 
CCCP remained endo H sensitive, we were able to monitor 
the rate at which enzymes were recovered from the ER. As 
seen in Fig.  8, the kinetics of recovery were similar to the 
kinetics of redistribution. A BrA-free period of I0 min was 
sufficiently long to maintain G protein in an endo H-sensi- 
tive state. Shorter recovery periods gave intermediate results. 
Thus,  the kinetics of enzyme recovery from the ER mea- 
sured by this assay were consistent with the recovery of G 
protein previously observed by immunofluorescence. Recov- 
ery of enzymes from the ER was also energy dependent. If 
CCCP was added to cells and BFA removed immediately 
after a pulse-label, G protein became endo H resistant, sug- 
Figure 6. Kinetics of enzyme redistribution. BFA 
was added to cells for the indicated periods of time 
after which CCCP was added to prevent further 
redistribution. The cells were incubated for an ad- 
ditional 90 min before lysis, immunoprecipitation, 
and endo H digestion (+). The labeling period was 
for 10 min. Thus, for the 2.5-min treatment peri- 
od,  BFA was added for the final 2.5 min of the 
labeling period before CCCP addition. BFA was 
removed from cells  5 rain after the addition of 
CCCP, and the cells incubated with CCCP alone 
for the remaining 85 min. However, for the 0-min 
time-point,  the BFA and CCCP were added im- 
mediately after the labeling period and the BFA 
was  not  removed,  showing that  CCCP  blocked 
BFA-induced redistribution of Golgi enzymes. 
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dence  of enzyme redistribu- 
tion. Cells were labeled for 10 
min at 37°C and then chased 
in the presence of BFA at 37, 
20, 15, or 0°C as indicated for 
90 or 180 min. The ceils were 
lysed, the G protein immuno- 
precipitated,  and. incubated 
overnight with (+) or without 
(-) endo H. To show that pro- 
cessing itself was not inhibited 
at  15°C, cells  were  treated 
with BFA for 30 min and la- 
beled for 10 min at 37°C, and then incubated at 15°C for 180 min. G protein was endo H sensitive immediately after the labeling period 
(not shown) but became fully resistant to endo H after 3 h at 15°C (far right lanes). 
gesting that enzyme recovery was prevented or at least great- 
ly inhibited  (Fig.  4  D).  Finally,  we found that enzyme re- 
covery occurred at 20°C  (not shown). 
Kinetics of  G Protein Transport after Removal of  BFA 
Since G  became endo H resistant in the ER in the presence 
of BFA, we had to rely on a different processing step to moni- 
tor G  protein transport to the Golgi apparatus.  Addition of 
sialic acid to G  protein, a trans-Golgi event (Kornfeld and 
Kornfeld, 1985; Farquhar,  1985), is easily detected by SDS- 
PAGE (see Fig. 4 A) and does not occur in the presence of 
BFA (see Fig.  4  B).  Cells were continuously treated with 
BFA  starting with a  30-min pretreatment before a  10-rain 
pulse-label  and  30-min  chase.  Cells  were  then  placed  in 
BFA-free medium for different periods of time. As shown in 
Fig. 9, G protein became completely endo H resistant 30 rain 
after BFA removal, and addition of sialic acid was largely 
complete by 45 min. Since G protein acquires a juxtanuclear 
position by  15  min  after BFA  removal (Fig.  1 D),  it  was 
somewhat surprising that an additional 30 rain was required 
before sialic acid addition was complete. This discrepancy 
may indicate that  additional  time is  required  before func- 
tional reassembly of the Golgi complex is complete. 
Transport of  G Protein from the 
Medial Goigi to the ER 
Having shown that BFA induced the return of resident Golgi 
proteins to the ER,  it was important to determine whether 
G  protein was similarly effected. We first used indirect im- 
munofluorescence. Cells in which G  protein was restricted 
to the ER by BFA treatment were washed and incubated for 
15 min at 37°C in the absence of BFA. As previously shown 
in Fig. 1, B-D, G protein rapidly acquired ajuxtanuclear dis- 
tribution after BFA removal. If BFA was added again for 5 
min after a  15-min washout period, G protein was found in 
perinuclear vesicles (Fig.  1 E). After an additional 5 min in 
the  presence of BFA,  a  reticular  staining  pattern  resulted 
(Fig.  1 F).  Thus, it appeared that the BFA block could be 
reimposed even after G  protein had reached the Golgi ap- 
paratus,  and that the G  protein was returned to the ER. 
For more direct evidence that G protein was recycled to the 
ER, we used tsO45.  As mentioned above, tsO45  G  protein 
is arrested in the ER at 40°C. At the permissive temperature 
of 32°C, tsO45 G protein is exported from the ER and trans- 
ported to the cell surface normally (Balch et al.,  1986).  Im- 
portantly, once tsO45 G  protein leaves the ER its transport 
is no longer temperature sensitive (Balch et al., 1986). Thus, 
tsO45 chased into the cis-Golgi  at 32°C is transported to the 
cell surface normally even if the  cells are  shifted back to 
40°C (Balch et al.,  1986;  Balch and Keller,  1986). We used 
this useful characteristic to determine if G protein, once de- 
livered to the Golgi complex, is returned to the ER upon BFA 
treatment. 
Cells infected with tsO45 were treated with 10/~M monen- 
sin at 32°C.  In the presence of monensin, transport of viral 
proteins from the medial to trans-Golgi is inhibited (Gritliths 
et al.,  1983). 3 h after infection, cells were treated anisomy- 
cin  to inhibit protein synthesis and incubated  for an addi- 
tional 30 rain to allow all of the G  protein to accumulate at 
the monensin block. As expected, the G protein was resistant 
to endo H but unsiaylated (not shown). When fixed permea- 
bilized  cells  were  examined  by  indirect  immunofluores- 
cence, juxtanuclear staining characteristic of the Golgi ap- 
Figure 8. Kinetics of enzyme recovery. 
Cells were treated with BFA for 30 min 
to induce complete redistribution of Gol- 
gi enzymes  to the ER.  The ceils were 
then incubated without BFA for the indi- 
cated  periods  of time before  addition 
of CCCP to prevent further  membrane 
transport.  The ceils were labeled for 5 
min immediately before the addition of 
CCCP. For the 2.5-min washout period,  cells were treated with BFA for 27.5 min.  [3~S]Methionine was then added along with the BFA 
for 2.5 min. The medium was then replaced with methionine-free medium containing [sSS]methionine but without BFA for a final 2.5 min 
before addition of CCCP. 
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removal.  Cells were treated  with BFA for 30 min be- 
fore labeling  with [35S]methionine for 10 rain.  Cells 
were lysed at this time (t =  -30) or incubated  for a 
further 30 min in the presence of BFA and excess cold 
methionine.  The BFA was then removed for 0, 15, 30, 
45, or 60 min before cells were lysed.  G protein was 
immunoprecipitated  and digested with endo H as indi- 
cated  (-/+). 
paratus was observed (Fig.  10 A). G protein was not detected 
on the cell surface. BFA was then added to cells for 15 min, 
after which monensin was removed, and the cells maintained 
in BFA. By 30 rain,  a  reticular pattern characteristic of ER 
was observed (Fig.  10 B). To determine if this pattern truly 
represented ER, the cells were shifted to 40°C and the BFA 
removed for 60 min. Transport of G protein to the Golgi ap- 
paratus or cell surface monitored by immunofluorescence or 
addition of sialic acid was not observed. We also found that 
the protein lost reactivity withantibody 114, which does not 
efficiently  immunoprecipitate  ER-restricted  tsO45  at 40°C 
(see Fig. 2 A), and ~40-50%  of the protein sedimented in 
aggregated  form on  sucrose  gradients  (not  shown).  These 
results indicated that all or at least most of the protein had 
in fact been returned to the ER (Fig.  10,  C and D) and that 
it reacquired a conformation characteristic of ER-restricted 
tsO45. 
Identical results were obtained when tsO45 G protein was 
accumulated  at  a  site  between  the  ER  and  cis-Golgi  by 
prolonged incubation at 15°C (Balch et al.,  1986; Balch and 
Keller,  1986).  tsO45 G  protein is transported to the surface 
from this intermediate compartment normally when cells are 
returned  to  40°C  (Balch  et  al.,  1986;  Balch  and  Keller, 
1986).  However, if BFA was added to cells when they were 
shifted from 15 to 40°C, G protein acquired instead a reticu- 
lar distribution  identical to that shown in Fig.  10, B  and C 
and was not transported  to the cell surface,  indicating  that 
it had been returned  to the ER (not shown). 
Discussion 
Previous studies have examined the effects of BFA on exocy- 
tosis in several cell types. BFA reversibly inhibits the secre- 
tion of soluble  proteins  by hepatocytes  and  pituitary  cells 
(Misumi et al.,  1986;  Magner and Papagiannes,  1988),  as 
well as delivery of VSV G protein to the cell surface (Takat- 
suki  and  Tamura,  1985).  Ultrastructural  examination  of 
BFA-treated hepatocytes revealed that albumin accumulated 
in the ER, which became dilated upon prolonged incubation 
with BFA (Fujiwara et al.,  1988). Most interestingly, a mor- 
phologically identifiable Golgi complex disappeared within 
15 min of adding BFA to these cells. In addition, studies have 
Figure 10. Redistribution  of G 
protein from the medial Golgi 
to the ER. Ceils infected with 
ts045  were  incubated  in  the 
presence of 10 #M monensin 
at 32°C for 3 h.  Anisomycin 
was added for 30 min (as well 
as for the remainder of the ex- 
periment)  to  prevent  further 
synthesis  of G protein  and to 
allow  'existing  molecules  to 
accumulate in the medial Gol- 
gi.  Cells  were fixed and pre- 
pared for indirect  immunoflu- 
orescence  using  monoclonal 
antibodies  to  G  protein.  A 
shows  permeabilized  cells  at 
the end of the monensin incu- 
bation.  BFA was  then  added 
for a  15-min  overlap  period 
with  monensin,  after  which 
the  monensin  was  removed 
and  the  cells  incubated  with 
BFA alone for an additional 30 
min (B).  The cells  were then 
shifted  to 40°C and the BFA 
removed for 1 h C, +  TX100; 
D,  -  TX100).  Bar,  15/~m. 
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retain  high-mannose,  endo  H-sensitive  oligosaccharides, 
which supported the conclusion that BFA acted by inhibiting 
ER to Golgi transport (Takatsuki and Tamura, 1985; Misumi 
et al.,  1986). 
Our results  were consistent with the reported effects of 
BFA but with an important exception: G  protein was  first 
trimmed to MansGlcNAc2  after which it acquired endo H 
resistance. Clearly, G protein was exposed to and processed 
by both cis- and medial Golgi enzymes in BFA-treated cells. 
Addition of sialic acid,  a  trans-Golgi event,  was  not ob- 
served. Our results are in disagreement with those of Takat- 
suki and Tamura (1985) who found that G protein remained 
endo H sensitive in the presence of BFA. The reasons for this 
discrepancy are not clear, but may be related to cell type, 
concentration of BFA used, or length of treatment. By retain- 
ing G protein in the ER via depletion of cellular ATP or by 
use of tsO45, which is restricted solely to the ER at 40°C, 
we were able to show that processing occurred in the ER and 
was not due to coretention of newly synthesized processing 
enzymes, an unlikely prospect to begin with in VSV-infected 
cells.  Thus,  processing  had  to  arise  from the  actions  of 
preexisting Golgi enzymes.  Since ER-restricted G  protein 
was processed, Golgi enzymes must be redistributed to the 
ER.  The relatively slow rate of processing in the presence 
of BFA might be accounted for by dilution of Golgi enzymes 
in the larger surface area of the ER (Grifliths et al.,  1984), 
nonsequential prosentation of G  protein to processing en- 
zymes, or by a difference in the ER environment relative to 
the Golgi complex. Our results are in agreement with those 
of Lippincott-Schwartz et  al.  (1989),  who  have  recently 
shown that Mannosidase II was redistributed to the ER in 
BFA-treated ceils by immunoelectron microscopy and that 
the trans-Golgi was largely unaffected. 
Characteristics  of  Retrograde  Transport and Recovery 
Certainly one of the  most  impressive features of BFA-in- 
duced redistribution of Golgi enzymes to the ER was the 
speed  with  which  it  occurred.  Partial  processing of ER- 
restricted G protein was detected as soon as 2.5 min after ad- 
dition of BFA. The rate at which ER-restricted G protein be- 
came endo H  resistant correlated with the length of BFA 
treatment up to 15 min. Longer incubation times did not in- 
crease the rate of processing. We interpreted these results to 
mean that treatment times of <15 min resulted in incomplete 
redistribution of cis- and medial Golgi enzymes to the ER, 
and that the concentration of these enzymes in the ER was 
rate limiting for processing. We concluded that redistribu- 
tion was completed sometime between 10 and 15 min after 
addition of BFA. Furthermore, it seems likely that the entire 
cis- and  medial Golgi are  delivered to the  ER since:  (a) 
tsO45 G protein localized to the medial Golgi by incubation 
with  monensin  was  quantitatively  returned  to  the  ER by 
BFA, and (b) virtually no cis- and medial Golgi cisternae can 
be  detected  in  BFA-treated  cells  (Fujiwara  et  al.,  1988; 
Lippincott-Schwartz et al.,  1989). 
Depletion of cellular ATP by CCCP effectively abolished 
redistribution. Since transport steps are differentially sensi- 
tive to ATP depletion, it will be interesting to more carefully 
titrate  the  effects of reduced ATP levels on BFA-induced 
redistribution (Persson et al., 1988). Redistribution was also 
blocked by incubation at 15°C,  a temperature at which pro- 
teins in transit from the ER to the Golgi complex have been 
found to accumulate in an intermediate compartment whose 
structure and function is poorly characterized (Saraste and 
Kuismanen, 1984; Tartakoff, 1986). The fact that redistribu- 
tion was inhibited at 15 but not 20°C may indicate involve- 
ment of this compartment in the redistribution process. 
Recovery of Golgi proteins from the ER occurred under 
the same general parameters as those for redistribution. If 
BFA was removed from cells for as little as 10 min, process- 
ing of ER-restricted G protein could no longer be detected. 
Recovery  was  energy  dependent  and  occurred  at  20°C. 
tsO45 G protein was retained in the ER at 40°C after removal 
of BFA, showing that the quality control mechanisms that re- 
tain misfolded proteins were still operational. While retrieval 
of Golgi enzymes from the ER was rapid, transport of G pro- 
tein from the ER to the trans-Golgi occurred more slowly 
than in untreated controls. Though G protein acquired a jux- 
tanuclear distribution characteristic of the Golgi complex 15 
min after removal of BFA, an additional 30 min was required 
before sialic acid was added. Apparently, it may take addi- 
tional  time  for the  Golgi  apparatus  to  functionally reas- 
semble. 
Possible Mechanisms of  Action 
Certainly the most intriguing mechanism to account for BFAs 
effects would be if the compound enhances or reveals a con- 
stitutive Golgi to ER recycling pathway by blocking transport 
from the ER. If BFA selectively blocks transport from the 
ER, then recycling from the "donor" compartment(s) would 
continue unopposed.  Since proteins from the intermediate 
compartment and both the cis- and medial Golgi are redis- 
tributed to the ER,  recycling may occur directly from all 
three sites.  Alternatively, any one of these organelles could 
be the primary donor, and other organelles with which it 
communicates closely might also be affected. Unopposed re- 
cycling from the cis-Golgi, for example, might eventually de- 
plete  the  medial  Golgi  and  intermediate compartment as 
well. A careful kinetic analysis of the rates at which cis- and 
medial Golgi markers are returned to the ER may differenti- 
ate between these possibilities. We note that the trans-Golgi, 
which  has  been  implicated  in  other  recycling  pathways, 
seems  to  be  excluded from this  circuit  (Farquhar,  1985; 
Snider and Rogers,  1985; Grifiiths and Simons,  1986). 
The delivery of resident and itinerant Golgi proteins to the 
ER indicates that at least one component of a constitutive re- 
cycling pathway must be vesicular in nature. Returning vesi- 
cles would help replace lipid lost from the ER in the form 
of transport vesicles. However, could a vesicular recycling 
pathway by itself return all of the necessary lipid to the ER? 
Wieland et al. (1987) have estimated that half of the phospho- 
lipids in the ER are transported to the Golgi apparatus every 
10 min. De novo synthesis could compensate for only a frac- 
tion of this, so the remainder must be returned by recycling, 
probably from the Golgi complex and/or intermediate com- 
partment.  Given the relative surface areas of the ER and 
Golgi complex, Wieland et al.  (1987) proposed that Golgi 
lipids have a half-time of only 1-2 rain before being recycled. 
The half-time for redistribution of the cis- and medial Golgi 
to the ER in BFA-treated cells appears to be on the order of 
6-7 min.  If these estimates are correct, then an additional 
nonvesicular recycling pathway may exist solely for the re- 
turn of lipid to the ER. Such a pathway would also serve to 
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sure vectorial transport  (Wieland et al.,  1987).  While evi- 
dence for a nonvesicular  recycling pathway  is lacking,  the 
presence of a vesicular mechanism does not necessarily rule 
it out given these considerations. 
A constituitive, vesicular recycling pathway might also re- 
trieve "escaped" ER proteins. Pelham has proposed that solu- 
ble  ER  proteins  containing  the  COOH-terminal  KDEL 
retention signal might not be strictly retained due to the fact 
that a receptor present in sufficient quantity to bind all KDEL 
proteins has not been identified (Munro and Pelham,  1987; 
Pelham, 1988) and KDEL proteins seem to be able to diffuse 
freely in the ER (Ceriotti and Colman,  1988). Rather, some 
fraction of soluble ER proteins might escape only to be re- 
covered by a salvage pathway, in which a KDEL receptor in 
a  post-ER compartment  recognizes  and returns  the errant 
protein (Pelham, 1988; Warren,  1987). Since we have shown 
that Golgi enzymes are functional in the ER environment and 
resident ER glycoproteins are generally not processed (Lewis 
et al.,  1985;  Liscum et al.,  1983;  Rosenfeld et al.,  1984; 
Brands et al.,  1985), a vesicular recycling pathway must be 
relatively selective in order to prevent  significant return of 
Golgi proteins to the ER. Proteins such as a putative KDEL 
receptor  might  selectively  be  incorporated  into  recycling 
vesicles while other proteins are excluded or incorporated at 
a low bulk-flow rate. A relatively low rate of reflu x might go 
undetected for several reasons, including recycling from the 
intermediate compartment,  delivery to a subdomain of the 
ER, and a mechanism to repair or turnover inappropriately 
modified ER proteins. In the presence of BFA, selectivity is 
apparently  lost. BFA might either disrupt mechanisms that 
exclude Golgi proteins or unopposed recycling might con- 
centrate resident and intinerant molecules to the point where 
they  are  incorporated  into  recycling vesicles  at  an  abnor- 
mally high bulk rate. 
An alternative  mechanism for the effects of BFA would in- 
voke the cis- and medial Golgi as the target organs for its ac- 
tion.  If BFA causes the Golgi to vesiculate and  fuse inap- 
propriately  with  the  ER,  then  the  apparent  "block"  in 
transport from the ER might simply be due to the disappear- 
ance  of  the  Golgi  apparatus.  This  proposed  mechanism 
might bear some analogy with mitotic cells (Fujiwara et ai., 
1988),  in which the Golgi apparatus  vesiculates and trans- 
port between the ER and Golgi is blocked though the Golgi 
apparatus retains its integrity (Featherstone et al.,  1985).  In 
BFA-treated  cells, ER to Golgi transport  is blocked and the 
Golgi vesiculates, but fusion with the ER also occurs. IfBFA 
in some way overrides the mechanisms  that prevent  inap- 
propriate  fusion events, then the observed effects may have 
little to do with a Golgi to ER recycling pathway. 
Summary 
We have shown that both resident and itinerant proteins are 
transported  from the intermediate compartment and both the 
cis- and medial Golgi to the ER when cells are incubated 
with BFA.  The trans-Golgi was  unaffected.  Whether  this 
reflects  an  underlying  Golgi  to  ER  recycling  pathway  or 
represents  artifactually  induced  fusion  between  the  or- 
ganelles remains to be determined. It is obvious and perhaps 
likely that BFA, like other compounds that inhibit membrane 
transport,  may affect multiple cellular processes.  The two 
scenerios discussed above are perhaps the simplest that can 
account for the observed results. More detailed studies will 
have to be performed to clarify the effects of BFA and to ex- 
plain its actions. 
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